PMID: 9444441Jan 28, 1998Paper

Topiramate: a review of preclinical, pharmacokinetic, and clinical data

Clinical Therapeutics
W E Rosenfeld

Abstract

The antiepileptic drug (AED) topiramate is a monosaccharide derivative with a sulfamate functionality. It modulates voltage-dependent sodium conductance, potentiates gamma-aminobutyric acid-evoked currents, and blocks the kainate/AMPA (alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid) subtype of the glutamate receptor. Topiramate is rapidly absorbed and has linear, proportional, steady-state pharmacokinetics. It has no known clinically significant effect on plasma levels of carbamazepine, valproic acid, or phenobarbital, although it may increase plasma concentrations of phenytoin in some patients. When topiramate is used with hepatic enzyme-inducing AEDs, its plasma concentrations are approximately 50% lower than when it is administered alone. The efficacy of topiramate 200 to 1000 mg/d administered in two divided doses as adjunctive therapy for partial-onset seizures was investigated in five double-masked, placebo-controlled trials. The median percentage reduction in average monthly seizure frequency from baseline was 12% for placebo, compared with 30% for the 200-mg/d group and 48% for the 400-mg/d group. At a dosage of 400 mg/d, a seizure reduction of 75% or greater was seen in 22% of topiramate patients, compared wi...Continue Reading

References

Jul 1, 1994·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·P N Patsalos, J W Sander
Jun 1, 1993·Clinical Pharmacokinetics·M Bialer

❮ Previous
Next ❯

Citations

Jun 5, 2012·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·N Cárdenas-RodríguezM Ruíz-García
Sep 18, 2008·Current Pain and Headache Reports·William B Young
Jul 31, 2013·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Marija JovanovićBranislava Miljković
May 10, 2005·Epilepsy & Behavior : E&B·Qian ZhaoGregory L Holmes
Feb 10, 2000·European Journal of Pharmacology·G De SarroA De Sarro
May 19, 2001·Neurologic Clinics·K D Holland
Apr 18, 2003·Pediatric Neurology·Sarah A SmathersMichael A Nigro
Oct 26, 2002·Epilepsy Research·Byung Ho ChaGregory L Holmes
Nov 3, 2006·Nature Reviews. Drug Discovery·Dunstan Cooke, Steve Bloom
Feb 27, 2004·Cephalalgia : an International Journal of Headache·P RossiG Nappi
Sep 27, 2003·Cephalalgia : an International Journal of Headache·M SilvestriniL Provinciali
Oct 3, 2001·Epilepsia·W O TatumUNKNOWN PADS Investigators. Post-marketing antiepileptic drug survey
Oct 9, 2002·Epilepsia·Eric H KossoffEileen P G Vining
Sep 4, 2004·Epilepsy Currents·Jacqueline A. French
Jan 15, 2005·Journal of Child and Adolescent Psychopharmacology·Antonio Y HardanBenjamin L Handen
Jan 18, 2005·Alcoholism, Clinical and Experimental Research·Kara I Gabriel, Christopher L Cunningham
Aug 27, 2003·Southern Medical Journal·Kristina M KlineKaren F Malnar
Dec 13, 2005·Clinical Neuropharmacology·Marco BartoliniLeandro Provinciali
Nov 30, 2004·Cephalalgia : an International Journal of Headache·R J Storer, P J Goadsby
Dec 21, 2004·Cephalalgia : an International Journal of Headache·W B Young, T D Rozen
Feb 14, 2006·Cephalalgia : an International Journal of Headache·M S MatharuM Swash
Sep 15, 2006·Seminars in Dialysis·Rubeen K IsraniJeffrey S Berns
Sep 3, 2011·Epilepsia·Adel A H MahmoudMohamad Al Tannir
Jan 1, 2009·BMJ Case Reports·A S Cohen, P J Goadsby
Dec 19, 2006·Journal of Neurology, Neurosurgery, and Psychiatry·A S Cohen, P J Goadsby
Apr 24, 2004·Annals of General Hospital Psychiatry·Kimberly D McLaren, Lauren B Marangell
Apr 23, 2005·Annals of General Psychiatry·Danilo Arnone
May 12, 2010·Clinical Interventions in Aging·B R Sommer, H H Fenn
Aug 26, 2014·Pharmacological Reports : PR·Monika BanachKinga K Borowicz
Dec 6, 2011·Advanced Drug Delivery Reviews·Devaiah VytlaJames J Chambers
Nov 26, 2010·Pediatric Neurology·Shannon M Standridge
Nov 26, 2015·Frontiers in Neuroscience·Manoranjan S D'Souza
Jan 9, 2008·Headache·Abdulkadir KoçerSefika Okuyucu
Jun 17, 2006·Acta Neurologica Scandinavica. Supplementum·E Ben-MenachemF Vajda
Sep 20, 2007·Alcoholism, Clinical and Experimental Research·Garth A Hargreaves, Iain S McGregor
Jan 27, 2011·BJU International·Vishwanath S HanchanaleAdrian D Joyce

❮ Previous
Next ❯

Related Concepts

Related Feeds

Ataxias (MDS)

Ataxia is a neurological condition characterized by lack of voluntary coordination of muscle movements including loss of coordination, balance, and speech. Discover the latest research on ataxia here.

Ataxia

Ataxia is a neurological condition characterized by lack of voluntary coordination of muscle movements including loss of coordination, balance, and speech. Discover the latest research on ataxia here.

Ataxias

Ataxia is a neurological condition characterized by lack of voluntary coordination of muscle movements including loss of coordination, balance, and speech. Discover the latest research on different types of ataxias here.